Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Most recent report
- 10-Q, filed Aug 7, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 886163
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 51
News 8 of 195
Prospectuses and Registrations 8 of 11
- S-8 Registration statement for an employee plan Jul 22, 2026
- S-3ASR Automatic shelf registration Feb 27, 2026
- S-8 Registration statement for an employee plan Jul 9, 2024
- S-8 Registration statement for an employee plan Mar 1, 2024
- S-3ASR Automatic shelf registration Sep 30, 2022
- S-8 Registration statement for an employee plan Aug 10, 2022
- S-8 Registration statement for an employee plan Jun 13, 2022
- S-8 Registration statement for an employee plan Jan 27, 2021
Proxies 8 of 32
- DEFA14A Extra proxy material May 18, 2026
- DEFA14A Extra proxy material Apr 28, 2026
- DEFA14A Extra proxy material Apr 27, 2026
- DEFA14A Extra proxy material Apr 21, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2026
- DEFA14A Extra proxy material Apr 22, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 22, 2025
- DEFA14A Extra proxy material Jun 3, 2024
Ownership 8 of 662
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 13, 2026
- 144 Notice of a proposed sale of restricted stock Aug 12, 2026
- 144 Notice of a proposed sale of restricted stock Aug 12, 2026
- 4 Insider reported a trade Aug 4, 2026
- 4 Insider reported a trade Jul 6, 2026
- 4 Insider reported a trade Jul 6, 2026
Other 8 of 49
Everything here comes from Ligand Pharmaceuticals Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.